FDA Inspection 1304746 - Brio Pharmaceuticals Inc - February 27, 2026

Record Details

This FDA Inspection record concerns Brio Pharmaceuticals Inc, with an inspection on February 27, 2026, issued by the Dallas District Office, covering human drugs.

Company: Brio Pharmaceuticals Inc
Inspection Date: February 27, 2026
Product Type: Human Drugs
Office: Dallas District Office

Open in Dashboard

ID · 215855d7-cef6-4306-9ed7-1cf6d2c8aaba

Violation Codes2

21 CFR 211.166(a)21 CFR 211.22(d)

Full citation text and observation details available on the Dashboard.